Lenvatinib para cáncer de tiroides. Aspectos prácticos.

Lenvatinib (Lenvima) is a drug approved for various types of cancer, including thyroid cancer. This short talk reviews the basics of this drug. Here's the link to my article on tyrosine kinase inhibitors such as sorafenib, lenvatinib, cabozantinib, and vandetanib, and future drugs such as RET and NTRK inhibitors (selpercatinib, pralsetanib, larotrectinib, entrectinib): http://revistaendocrino.org/index.php... Here's a link to a talk I gave with Professor Felipe Fierro on the management of adverse events with TKIs such as sorafenib:    • Experiencias en vida real de pacientes con...   If you like this video, remember to like it and subscribe to this channel. Remember to follow me on my social media Instagram: @endocrinoupdate_